A Better Family Plan

Dr. Clowse is assistant professor of medicine in the Division of Rheumatology and Immunology, director of the Duke Autoimmunity in Pregnancy Clinic and Registry, and co-director of the Duke Lupus Clinic at Duke University Medical Center in Durham, N.C.

References

1. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005;32(9):1709-1712.
2. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30(10):2127-2132.
3. Buyon JP, Clancy RM. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus. Autoimmunity. 2003;36(1):41-50.
4. Parke A. Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases. Lupus. 2006; 15(11):808-813.
5. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med. 2003;157(4):397-402.
6. Priori R, Medda E, Conti F, et al. Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus. 2003; 12(10):735-740.
7. Clowse MEB, Jamison MG, Myers E, James AH. National study of medical complications in SLE pregnancies. Arthritis Rheum. 2006;54(9 (suppl.)):S263.
8. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006; 54(8):2550-2557.
9. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003;82(5): 299-308.
10. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum. 1993;36(10):1392-1397.
11. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514-521.
12. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107(2 Pt. 1):293-299.
13. Petri M, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24):2550-2558.
14. Sanchez-Guerrero J, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24):2539-2549.
15. Ruano R, Fontes RS, Zugaib M. Prevention of preeclampsia with low-dose aspirin – a systematic review and meta-analysis of the main randomized controlled trials. Clinics. 2005;60(5):407-414.
16. Chakravarty EF, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192(6):1897-1904.
17. Costedoat-Chalumeau N, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48(11):3207-3211.
18. Clowse ME, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640-3647.
19. Ostensen M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.
20. Clowse MEB, Magder LS, Witter F, Petri M. Azathioprine use in lupus pregnancy. Arthritis Rheum. 2005; 52(9 (suppl.)).
21. Pradat P, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67(12):968-970.
22. Clowse MEB, Magder LS, Petri M. Complement and double-stranded DNA antibodies predict pregnancy outcomes in lupus patients. Arthritis Rheum. 2004; 50(9(suppl.)):S408.
23. Gordon C, Kilby MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Lupus. 1998;7(7):429-433.